AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 14604835
Drug: New treatments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New treatments to reduce expansion rate by >50%
Trial: 14604835
Drug: Statins as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statins as a proposed treatment
Trial: 12439840
Drug: Steroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid treatment for 6 months
Trial: 12439840
Drug: Steroids and
RxNorm normalized name: Corticosteroids and mydriatics in combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids and azathioprine
Trial: 12439840
Drug: Steroids and
RxNorm normalized name: Corticosteroids and mydriatics in combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids and cyclophosphamide
Trial: 10353328
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg folic acid
Trial: 10353328
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg vitamin B6
Trial: 10353328
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 0.3 mg folic acid and 120 mg vitamin B6
Trial: 10353328
Drug: 0.6 mg
RxNorm normalized name: thymol 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg folic acid
Trial: 1934661
Drug: D +
RxNorm normalized name: Liver Desiccated + B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D + W (dipyridamole and low-dose warfarin)
Trial: 1934661
Drug: Original treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original treatment group (27 patients)
Trial: 1934661
Drug: New treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New treatment group (n = 13)
Trial: 6119937
Drug: pindolol (beta-blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pindolol (beta-blocker with intrinsic sympathomimetic activity)
Trial: 6119937
Drug: beta-blockers without
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-blockers without intrinsic sympathomimetic activity
Trial: 31987567
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (resting for 2 minutes without treatment)
Trial: 28800211
Drug: Generic dofetilide
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Generic dofetilide 0.5 mg
Trial: 24840659
Drug: Nighttime bending
RxNorm normalized name: Flonase Nighttime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nighttime bending brace treatment
Trial: 2066441
Drug: Tetracycline-immobilized cross-linked
RxNorm normalized name: riboflavin 5'-phosphate
DrugBank: Flavin mononucleotide (DB03247)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline-immobilized cross-linked collagen film (TC film) administered 4 times at 1-week intervals
Trial: 2066441
Drug: Root planing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Root planing (RP) treatment
Trial: 2066441
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (TC + RP)
Trial: 6367861
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of adjuvant chemotherapy with CMF
Trial: 6367861
Drug: 12 months
RxNorm normalized name: Elecare HMO 0-12 Months
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 months of adjuvant chemotherapy with CMF
Trial: 6367861
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of CMF preceded by local-regional x-ray therapy (XRT)
Trial: 6367861
Drug: XRT treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XRT treatment arm
Trial: 31601357
Drug: RAFT -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RAFT - group cognitive-behavioural therapy (CBT) programme delivered by rheumatology tutor pairs (nurses/occupational therapists)
Trial: 30373553
Drug: 2 L
RxNorm normalized name: H-2 locus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 L Physioneal 1.36% glucose dialysis fluid
Trial: 30373553
Drug: 2 L
RxNorm normalized name: H-2 locus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 L Physioneal 3.86% glucose dialysis fluid
Trial: 24527531
Drug: On-time dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-time dosing of tadalafil (10 mg/20 mg, twice a week for 8 weeks)
Trial: 24527531
Drug: On-demand dosing
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: On-demand dosing of tadalafil (10 mg/20 mg before sexual activity)
Trial: 22205307
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg n-3 LCPUFAs as a supplement per day and a concomitant reduction in arachidonic acid intake
Trial: 20970603
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily prolonged-release tacrolimus (QD)
Trial: 20970603
Drug: Twice-daily tacrolimus
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily tacrolimus (BID)
Trial: 16366757
Drug: Caffeine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 2.5 mg/kg p.o.
Trial: 16366757
Drug: Caffeine 5.0
RxNorm normalized name: CAFFEINE 5.0 mg in 1000 mL TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 5.0 mg/kg p.o.
Trial: 11923693
Drug: Everolimus 0.75
RxNorm normalized name: everolimus 0.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 0.75 mg bid
Trial: 11923693
Drug: Everolimus 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 1.5 mg bid
Trial: 2658177
Drug: Ranitidine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (50 mg intravenously every 6 hours for 72 hours)
Trial: 2658177
Drug: No ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ranitidine treatment (control group)
Trial: 6113060
Drug: no treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no treatment control
Trial: 28280731
Drug: Tapered implant
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tapered implant with knife‐edge threads/nanostructured calcium‐incorporated surface (Anyridge®, Megagen)
Trial: 28280731
Drug: Cylindrical implant
RxNorm normalized name: Imperata cylindrica root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cylindrical implant with self‐tapping threads/sandblasted surface (EZPlus®, Megagen)
Trial: 23663579
Drug: Tirofiban and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirofiban and warfarin combined with aspirin and clopidogrel (observation group)
Trial: 22975664
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and clopidogrel (control group)
Trial: 21410840
Drug: Misoprostol moistened
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol moistened with normal saline solution (NSS)
Trial: 19462302
Drug: Sublingual nicotine
RxNorm normalized name: nicotine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nicotine replacement therapy (NRT)
Trial: 11494629
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) consisting of conjugated equine estrogens and medroxyprogesterone acetate (MPA)
Trial: 8483425
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine oestrogens (CEE) 0.625 mg/day over a 25‐day cycle each month (n = 28)
Trial: 8483425
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta‐oestradiol 50 micrograms/day over a 24‐day cycle each month (n = 28)
Trial: 8483425
Drug: CEE 0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE 0.625 mg/day every day of the month (n = 32)
Trial: 8483425
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control group, n = 30)
Trial: 3087619
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with Tegafur
Trial: 26593273
Drug: combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: combination of cTBS+iTBS, 1800 pulses/session for each
Trial: 22238630
Drug: DA medication
RxNorm normalized name: DAS-181
DrugBank: DAS-181 (DB15313)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA medication ON condition
Trial: 22238630
Drug: DA medication
RxNorm normalized name: DAS-181
DrugBank: DAS-181 (DB15313)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA medication OFF condition
Trial: 19009290
Drug: Whole-body low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Whole-body low-dose computed tomography (WBLDCT)
Trial: 7653443
Drug: Warfarin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin therapy (group 3b)
Trial: 59787
Drug: Subunit vaccines
RxNorm normalized name: covid-19, protein subunit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subunit vaccines containing hemagglutinin, neuraminidase, and nucleocapsids of A/Port Chalmers/1/73 (H3N2) influenza virus
Trial: 59787
Drug: Booster doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster doses of antigen
Trial: 59787
Drug: Intact influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intact influenza B virus vaccine
Trial: 59787
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of the subunit vaccines (1,400 chick cell‐agglutinating units)
Trial: 19646194
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg rosiglitazone
Trial: 15504990
Drug: Insulin (premixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (premixed 70/30)
Trial: 11182215
Drug: Cilostazol (100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol (100-200 mg, two or four times daily for 12 months)
Trial: 2903602
Drug: Spasmofen (narcotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spasmofen (narcotic combination drug)
Trial: 19231774
Drug: Intraoperative cone-beam
RxNorm normalized name: Pinus strobus cone extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative cone-beam computed tomography using a mobile isocentric C-arm (PowerMobil; Siemens Medical Solutions) with different tube currents (4.6 mA, 3.3 mA, 2.3 mA, 1.2 mA, and 0.5 mA) and a current tube voltage of 100 kV
Trial: 12480288
Drug: Granules containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granules containing 40% MCCh with ibuprofen
Trial: 3556257
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg povidone-iodine pessaries, taken twice daily for five consecutive days
Trial: 3556257
Drug: Placebo pessaries,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo pessaries, taken twice daily for five consecutive days
Trial: 18823487
Drug: Topical Lactobacillus
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Lactobacillus casei rhamnosus (Lcr35) vaginal capsules (10^9 CFU) for 7 days after antibiotic treatment
Trial: 18823487
Drug: Standard antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antibiotic therapy for 7 days
Trial: 11127762
Drug: estradiol 50
RxNorm normalized name: estradiol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: estradiol 50 mg (E)
Trial: 11127762
Drug: estradiol 50
RxNorm normalized name: estradiol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: estradiol 50 mg plus testosterone 50 mg implants (E&T)
Trial: 8708167
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 300 mg loading dose followed by continuous infusion of 1.2 mg/kg per h for 5 days
Trial: 27358417
Drug: Fe‐Beans (86
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe‐Beans (86 mg Fe/kg), consumed 2 times/d for 128 days
Trial: 27358417
Drug: Control‐Beans (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control‐Beans (50 mg Fe/kg), consumed 2 times/d for 128 days
Trial: 23860793
Drug: Coated implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coated implant
Trial: 23860793
Drug: Uncoated implant
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Uncoated implant
Trial: 18784532
Drug: Nonresorbable membrane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonresorbable membrane used to seal the lateral access window of the maxillary sinus after implant placement in 5 cases (group A)
Trial: 12552040
Drug: milameline (muscarinic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: milameline (muscarinic receptor agonist)
Trial: 10372249
Drug: Acarbose (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (n = 973, max dose 100 mg three times per day)
Trial: 8665111
Drug: 5% glucose
RxNorm normalized name: Dextrose/Water 5% Oral Solution [ENFAMIL 5% GLUCOSE IN WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glucose solution with 3 MBq of 99mtechnetium labelled DTPA
Trial: 8665111
Drug: iso‐osmotic maltodextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iso‐osmotic maltodextrin solution with 3 MBq of 99mtechnetium labelled DTPA
Trial: 8665111
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of gastric emptying rates between glucose and maltodextrin solutions
Trial: 8450107
Drug: Behavioral Marital
RxNorm normalized name: barbital
DrugBank: Barbital (DB01483)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral Marital Therapy (BMT)
Trial: 2002129
Drug: Insight-Oriented Marital
RxNorm normalized name: barbital
DrugBank: Barbital (DB01483)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insight-Oriented Marital Therapy (IOMT)
Trial: 22327894
Drug: Contour Profile
RxNorm normalized name: mometasone
DrugBank: Mometasone (DB00764)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contour Profile Gel breast implants
Trial: 9565933
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (NaHCO3) 0.3 g.kg‐1
Trial: 31911526
Drug: Tailored pharmacist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored pharmacist intervention including reminders, habit-based strategies, family support, counselling, and strategies to address drug-related problems.
Trial: 25628348
Drug: Endoscopic balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic balloon dilation with steroid injection
Trial: 25628348
Drug: Radial incision
RxNorm normalized name: INCISED NOTOPTERYGIUM RHIZOME OR ROOT (NOTOPTERYGIUM FRANCHETII)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radial incision and cutting with steroid injection
Trial: 23361846
Drug: Ticlopidine (CYP2B6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (CYP2B6 inhibitor), given orally for 4 days
Trial: 21809126
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (common needling on Zusanli (ST36), electroacupuncture on Sanyinjiao (SP6), Shuidao (ST28), and Scalp Reproduction Area, moxibustion on Shenque (CV8))
Trial: 21809126
Drug: Acupoint injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint injection with vitamin B12 at Sanyinjiao and Zusanli
Trial: 21809126
Drug: Acupoint injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint injection with vitamin B12
Trial: 17903567
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group conclusions favoring treatment efficacy
Trial: 15638817
Drug: L-arginine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (3 g daily for 3 weeks)
Trial: 9894821
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (20 mg d(‐1) syrup with multivitamin (2 x RDA))
Trial: 7659481
Drug: Whole-cell pertussis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-cell pertussis vaccine (WCL)
Trial: 2568805
Drug: Iotrolan 280
RxNorm normalized name: iotrolan 280 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iotrolan 280 (0.15 to 0.9 g I/kg body weight)
Trial: 2568805
Drug: Iotrolan 280
RxNorm normalized name: iotrolan 280 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iotrolan 280 (0.9 g I/kg body weight)
Trial: 29569351
Drug: Acupuncture therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture therapy (3 times a week for 4 weeks)
Trial: 21393644
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy combined with standard therapy (TENS, ultrasound therapy, kinesiotherapy)
Trial: 21393644
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (TENS, ultrasound therapy, kinesiotherapy)
Trial: 10803671
Drug: Iodixanol 270
RxNorm normalized name: IODIXANOL 270mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol 270 mg I/mL
Trial: 10803671
Drug: Iohexol 300
RxNorm normalized name: IOHEXOL 300MG/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iohexol 300 mg I/mL
Trial: 9032862
Drug: Gamma Knife
RxNorm normalized name: Gamma Cyclodextrin
DrugBank: Gamma cyclodextrin (DB19173)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma Knife treatment
Trial: 1909637
Drug: Gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil 600 mg b.i.d.
Trial: 1909637
Drug: Gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil 600 mg b.i.d. plus 4 g cholestyramine o.d.
Trial: 6614958
Drug: 5% fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% fluorouracil cream applied daily to vitiliginous lesions under occlusive dressings
Trial: 6614958
Drug: 5% fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% fluorouracil cream
Trial: 17609842
Drug: Horizontal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Horizontal therapy (HT)
Trial: 17609842
Drug: Sham horizontal
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham horizontal therapy (Control)
Trial: 7567311
Drug: Ceftibuten 9
RxNorm normalized name: ceftibuten 90 MG in 5 mL Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten 9 mg/kg once daily (max 400 mg)
Trial: 7567311
Drug: Cefaclor 40
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor 40 mg/kg/day in three divided doses (max 1 g/day)
Trial: 2095647
Drug: Immunoglobulin preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunoglobulin preparation (Pentaglobin) administered intravenously
Trial: 7272608
Drug: Guided mourning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided mourning treatment (facing cues concerning bereavement)
Trial: 7272608
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (avoiding cues concerning bereavement)
Trial: 29030864
Drug: Ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ingenol mebutate 0·015% gel
Trial: 24501015
Drug: telehealth problem-solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telehealth problem-solving therapy (tele-PST via Skype video call)
Trial: 24501015
Drug: in-person problem-solving
RxNorm normalized name: Psoriasin Problem Skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: in-person problem-solving therapy (PST)
Trial: 22819575
Drug: Intraperitoneal lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal lignocaine (20 ml of 0.5% lignocaine)
Trial: 22819575
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 ml of isotonic saline)
Trial: 20045576
Drug: IV prochlorperazine
RxNorm normalized name: Prochlorperazine
DrugBank: Prochlorperazine (DB00433)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV prochlorperazine with 12.5 mg diphenhydramine
Trial: 12464140
Drug: G. biloba
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G. biloba extract (Gibidyl Forte(R))
Trial: 7657737
Drug: Zoladex depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zoladex depot (single injection)